+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Halozyme Inc - logo

Halozyme was founded in 1998, the headquarters are located in San Diego, California. It is a biotechnology company that innovates cancer therapies that target the tumor microenvironment. PEGPH20, their main proprietary programme applies a unique approach to targeting solid tumors it may help make existing treatments more effective by allowing therapies to reach the tumor. Halozyme has teamed up with many partnering companies such as: Roche, Pfizer, Janssen, Baxalta, AbbVie and Lilly for the NHANZE™ drug delivery technology platform.

From
From
From
From
Contact Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Contact Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Epinephrine Autoinjector Market 2024-2028 - Product Thumbnail Image

Epinephrine Autoinjector Market 2024-2028

  • Report
  • November 2023
  • 154 Pages
  • Global
From
Pancreatic Ductal Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Pancreatic Ductal Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
HER2 Inhibitors Global Market Report 2024 - Product Thumbnail Image

HER2 Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Breast Cancer Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Breast Cancer Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
From
Loading Indicator